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To study the predictive value of biopsy lesions in IgA
nephropathy in a range of patient ages we retrospectively
analyzed the cohort that was used to derive a new
classification system for IgA nephropathy. A total of 206
adults and 59 children with proteinuria over 0.5g/24h/
1.73m2 and an eGFR of stage-3 or better were followed
for a median of 69 months. At the time of biopsy, compared
with adults children had a more frequent history of
macroscopic hematuria, lower adjusted blood pressure, and
higher eGFR but similar proteinuria. Although their outcome
was similar to that of adults, children had received more
immunosuppressants and achieved a lower follow-up
proteinuria. Renal biopsies were scored for variables
identified by an iterative process as reproducible and
independent of other lesions. Compared with adults, children
had significantly more mesangial and endocapillary
hypercellularity, and less segmental glomerulosclerosis and
tubulointerstitial damage, the four variables previously
identified to predict outcome independent of clinical
assessment. Despite these differences, our study found that
the cross-sectional correlation between pathology and
proteinuria was similar in adults and children. The predictive
value of each specific lesion on the rate of decline of renal
function or renal survival in IgA nephropathy was not
different between children and adults.
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Primary IgA nephropathy (IgAN) is the commonest
glomerular disease in children and adolescents who undergo
renal biopsy because of isolated microscopic hematuria or
hematuria with non-nephrotic proteinuria.1,2 Mild cases are
surely missed as screening programs do not exist, with the
exception of some Asian countries, including Japan, Korea
and Taiwan.3,4 From cohorts evaluated over relatively
short follow-up, prognosis of IgAN was initially considered
to be benign, but long-term studies have shown renal
survival rate from time of onset of 91–93% at 10 years and
80–87% at 20 years.5,6 In Europe, the majority of IgAN
patients who start renal replacement therapy do so between
the ages of 25 and 55, with 22% before the age of 30 years.7
Given a slow decline of renal function in IgAN, many of these
patients must have developed the disease as children.
Identifying those at risk of progression remains difficult
and clinical factors that predict outcome in adults, such as
reduced renal function and persistent hypertension, are less
frequent in children.1,8–10
Reports comparing lesions in renal biopsies of children
and adults with IgAN found greater mesangial hypercellu-
larity in children and greater glomerular sclerosis, matrix
expansion, crescent formation, severe interstitial, and arter-
iolar changes in adults.11–15 This observation suggests
different initial pathological features and/or earlier detection
in children. Furthermore, whether the predictive value of
biopsy lesions in IgAN applies similarly across the age
spectrum using multivariate analysis, including also clinical
data, has never been investigated.
To explore this, we compared the clinicopathological
features in children and adults from the cohort used by an
international consensus working group to derive a new
classification for IgAN, the Oxford classification.16,17 This
working group of nephrologists and pathologists has
proposed that four of the six lesions (mesangial and
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endocapillary hypercellularity, segmental glomerulosclerosis,
and tubular atrophy/interstitial fibrosis) are predictive of
outcome independent of clinical assessment. We investigated
whether the predictive value of biopsy lesions in IgAN
applied similarly regardless of age.
RESULTS
Children and adult clinical comparisons
Clinical assessment at the time of biopsy and during follow-
up was obtained retrospectively in 59 children (median age
13 years, range 4–17.9 years) and 206 adults from Europe,
Asia, and the Americas. Median follow-up time was
62 months in children and 77 months in adults (P¼ 0.02).
Gender and ethnicity ratios were similar in children and
adults. Children were more likely than adults to have a
history of macroscopic hematuria, to have lower adjusted
blood pressure, to receive less antihypertensive therapy, and
have higher initial estimated glomerular filtration rate
(eGFR) (Table 1) but had similar proteinuria at time of
biopsy. The interval between known renal abnormality and
the time of renal biopsy was obtained in 228 (86%) of
patients. This duration was significantly longer in adults than
in children (median value of 9 months compared to
2 months in children, P¼ 0.027), although the percentage
of patients with duration longer than two years was similar
(19% of children and 25% of adults, P¼ns). This subset of
patients had fewer endocapillary and extracapillary lesions,
and lower initial proteinuria, perhaps reflecting a milder
presentation warranting greater observation time.
Children received more immunosuppressants and protei-
nuria was lower during follow-up. Their rate of decline in
renal function was not statistically different from that of the
adults, but there was a non-significant trend toward lower
risk of a 50% decline in renal function or renal failure
(hazard ratio 0.48, 95% confidence interval 0.20–1.13,
P¼ 0.09).
No significant difference was found in initial and follow-
up mean arterial pressure (MAP) and proteinuria between
young children (p13.0 years of age, 29 patients) and
adolescents (age 13–17.9 years, 30 patients). Young children
were more likely to being treated with immunosuppressive
drugs, possibly in relation to a higher prevalence of mesangial
and endocapillary hypercellularity (see below). The rate of
decline in renal function was not significantly different in the
two groups (3.2±12.5 versus 2.2±8.5 ml/min/1.73 m2/
year).
Children and adult pathological comparisons
Histology slides from each case were reviewed by four
nephropathologists in median (range 3–5) and scored for six
reproducible and independent lesions identified by an
iterative process.16,17 Distributions according to age groups
are shown in Figure 1. Children’s biopsies showed signifi-
cantly more mesangial and endocapillary hypercellularity in
comparison with biopsies of adults, and young children had
significantly more than that in adolescents. As expected,
children had less chronic tubulointerstitial and vascular
damage than adults. Interestingly, for patients in the age
groups p13.0, 13–17.9 to 18–30 years, the prevalence of
segmental glomerulosclerosis increased (0, 10.14%, respec-
tively, P¼ 0.005, trend test on quartiles using Spearman
correlation), while endocapillary proliferation decreased (17,
3–0%, Po0.001, trend test). As expected from this observa-
tional study, presence of mesangial and endocapillary
hypercellularity, and presence of crescents strongly influenced
the prescription of immunosuppressants (Figure 2). Ethnicity
Table 1 | Clinical findings according to age group
Children (n=59) Adults (n=206) P-value
At time of biopsy
Median age (years) 13 (4–17.9) 35 (19–73)
Female 25% 28% 40.1
MAP (mmHg)a 84±10 102±17 o0.001
eGFR (ml/min/1.73m2)b 120±43 73±27 o0.001
Proteinuria (g/day)c 2 (0.5–7.8) 1.7 (0.5–18.5) 40.1
% Nephrotic 27% 30% 40.1
Previous macroscopic hematuria 60% 28% o0.001
Follow-up
Duration of follow-up (months) 62 (20–268) 77 (12–231) 0.02
MAP (mmHg)a 86±8 97±10 o0.001
Proteinuria (g/day)c 0.9 (0.1–7.0) 1.2 (0.2–9.3) 0.006
Treated with RAS blockade (ACEi, ARB) 56% 80% o0.001
Any immunosuppression 48% 24% 0.001
Prednisone 48% 24% 0.001
Other 17% 7% 0.02
Fish oil 25% 14% 0.03
Rate of decline in renal function (ml/min/1.73m2/year) 2.7±11 3.7±7.6 40.1
Abbreviations: ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; eGFR, estimated glomerular filtration rate; MAP, mean arterial pressure;
RAS, renin–angiotensin system.
aMAP was adjusted for gender and age for pediatric patients.
beGFR was estimated using the four-variable MDRD formula for adults and the Schwartz formula for children.
cProteinuria was expressed in g/24 h/1.73m2 in subjects aged less than 18 years and in g/day in adults (see Materials and Methods).
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had no significant effect on the pathological findings
(Table 1). Geographical differences between children are
shown in Table 2.
Clinicopathological correlations at the time of biopsy
Presence or absence of the six pre-specified lesions was not
significantly associated with eGFR and MAP in children at
the time of biopsy except for crescents: children with
crescents had a significantly lower eGFR compared with
those without (P¼ 0.03). There were too few children
with arterial and tubulointerstitial lesions to draw conclu-
sions on their effect on clinical presentation (data not
shown). The influence of hypercellularity (mesangial,
endocapillary, and extracapillary) and segmental glomerulo-
sclerosis lesions on the level of proteinuria was similar in
adults and children (Figure 3, interaction terms with age
P40.05 for each lesion versus proteinuria).
A history of macroscopic hematuria was much more
frequent in children than in adults (60 versus 28%,
Po0.001). In comparison with adults, children with a
history of macroscopic hematuria had more frequent (albeit
not significant) endocapillary and extracapillary proliferation
and fewer chronic lesions (Po0.002, for tubular atrophy/
interstitial fibrosis). History of macroscopic hematuria did
not predict rate of decline in renal function in either children
or adults when analyzed separately.
Applicability of the classification in children and adults
Previous study of the whole cohort16,17 identified four
pathological variables, mesangial hypercellularity score
(M0/1), segmental glomerulosclerosis (S0/1), endocapillary
hypercellularity (E0/1), and tubular atrophy/interstitial
fibrosis (T0/1/2), that retained predictive value in terms of
renal outcome independently of clinical assessment at onset
and follow-up (eGFR, MAP, and proteinuria). We performed
analyses while adding an interaction term with age to verify
whether the relationship between each lesion of interest and
outcome was modified by age. All interaction terms were
non-significant (P40.1), indicating that the predictive value
of pathology on the rate of decline in renal function and
survival from a combined event was not modified by the age
of the patient at biopsy.
Hence, children had significantly less segmental glomer-
ulosclerosis, tubular atrophy/interstitial fibrosis, and vascular
lesions, and significantly more endocapillary lesions than
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Figure 1 |Histological findings according to different age groups. Children represented 22% of the population and were considered as
the first quartile for age; adult patients were divided in three groups (quartiles 2, 3, and 4). Trend test was performed on quartiles using
Spearman correlation. Differences between children p13.0 and adolescents are also shown and discussed in the text.
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adults. These differences in the prevalence of lesions
contributed to a distinctly different prognosis between
children and adults. However, the predictive value of each
pathological variable on outcome was similar regardless of
age (Table 3). For instance, in children and adults, those
whose renal biopsies had minimal mesangial changes (M0),
mesangial hypercellularity (M1), and no endocapillary
proliferation (E0) showed different slopes of eGFR according
to the presence or absence of segmental glomerulosclerosis
(S1) (Table 3), showing that the classification is valid in both
age groups.
DISCUSSION
The proposed Oxford clinicopathological classification pro-
vides a new predictive tool on the basis of the lesions detected
at renal biopsy in patients with IgAN. While the traditional
approach to a classification was to list a series of relevant
lesions and group them according to expert opinions, the
proposed classification was determined using a methodology
that sequentially assessed reproducibility, colinearity,
optimal categorization, and independence from clinical
assessment.16,17
To assess the validity of the new Oxford classification of
IgAN in children, we took advantage of the wide age
spectrum of patients from the original cohort, all provided
with a renal biopsy suitable for reviewing and a complete
data set expanded over a long follow-up. This careful data
collection procedure was lacking in previous cohorts and
limited the clinical evaluation;15 we paid particular attention
to homogenizing units of measurement to allow comparison
of data in children and in adults, looking for the predictive
value of histological lesions in renal outcome.
As expected, children presented with a higher eGFR and
more frequent history of macroscopic hematuria. Given our
entry criteria, children and adults had similar baseline levels
of proteinuria. The rate of decline in renal function was also
similar in the two age groups, although the frequency of
progression to the end point of decline in renal function or
renal failure tended to be higher in adults. This finding
suggests a common natural history for children and adults
with IgAN, with a similar rate of progression. Adults detected
later in the clinical course than children would likely reach
the final end point more rapidly, having a lower initial eGFR
at the time of renal biopsy. However, important divergences
between children and adults must be emphasized.
First, differences in histological features should not be
disregarded and remarkable changes in lesion prevalence
were observed with increasing age despite similar initial
proteinuria. Highest mesangial and endocapillary hypercel-
lularity were found in younger children and progressively
decreased in adult age. Crescents were also more frequent at
younger age. In contrast, glomerular sclerosis, tubular/
interstitial fibrosis, and arteriosclerotic lesions were more
prevalent in older subjects. These features depict a disease
with greater active lesions in children, at least at similar levels
Table 2 | Geographical origins and clinicopathological presentation of 59 children with IgAN
Asia Europe (EU) Americas (Am) P-value
Number of patients 14 21 24
Ethnicity All Asian All Cauc 20 Cauc, 1 AA, 3 others
Histological findingsa
Mesangial hypercellularity (score) 0.9 (0.3–1.5) 0.8 (0.1–2.6) 1.4 (0.4–2.5) 0.009 Am4Asia and EU
Endocapillary hypercellularity (%) 5 (0–61) 7 (0–78) 16 (0–59) 40.1
Extracapillary hypercellularity (%) 1 (0–34) 5 (0–55) 3 (0–30) 40.1
Segmental glomerulosclerosis (%) 2.5 (0–24) 0 (0–25) 10.5 (0–50) 0.06
At time of biopsy
Gender M/F 6/8 18/3 20/4 0.008 EUaAm and Asia
Median age (years) 14 (7–17.9) 13 (4–17.9) 13 (7–17.9) 40.1
GFR initial (ml/min/1.73m2) 146±51 102±30 120±37 0.01 Asia4EU
MAP initial (mmHg) 77±10 88±10 85±8 0.02 AsiaoEU and Am
Proteinuria initial (g/day/1.73m2) 2.1 (0.5–6.2) 1.5 (0.6–5.1) 2.5 (1.1–7.8) 40.1
Abbreviations: GFR, glomerular filtration rate; IgAN, IgA nephropathy; MAP, mean arterial pressure.
aTubular atrophy/interstitial fibrosis and arterial lesions are not reported, because they were rare in children.
Cauc, Caucasian; AA, African American; others, other ethnicities.
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Figure 3 |Correlation between proteinuria and histological
findings. *Proteinuria was expressed in g/24 h/1.73m2 for
subjects aged less than 18 years and in g/day in adults
(see Materials and Methods).
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of initial proteinuria. Whether this can be generalized to all
IgAN patients is unknown as adult and pediatric participat-
ing centers may have different referral biases and did not
report the proportion of subjects screened that fulfilled the
entry criteria.
Second, younger patients received considerably more
immunosuppressive drugs during follow-up. This could
explain the lower follow-up proteinuria in children and
may influence the outcome. Given this, the rate of renal
function decline in children can be difficult to compare with
that in adults. It is possible, had no therapy been given,
that children would have experienced a significantly faster
rate of decline in renal function. In contrast, a recent report
considering only patients with IgAN and proliferative
changes, showed better renal survival in children or
adolescents as compared with that in adults.15 Although of
clinical importance, we remain very cautious in our
interpretation of the risk of progression in children.
The main thrust of this study was not to compare children
with adults with regards to outcome but to verify whether the
information at renal biopsy had a similar meaning in both
age groups. At the time of biopsy, cross-sectional correlations
between pathological findings and proteinuria were similar in
both age groups supporting the applicability of this
classification. Furthermore, during follow-up, the rate of
decline in renal function was similar in the two age groups
even when a combination of scores for different lesions was
considered. The multivariate analysis showed that the
predictive value of the four renal features (mesangial and
endocapillary hypercellularity, segmental glomerulosclerosis,
and tubular atrophy/interstitial fibrosis) was independent not
only from clinical data at renal biopsy but even from data
during follow-up. Notably, the value of the four variables
identified in the Oxford Consensus Classification for
prediction of final outcome was not influenced by the age
of the patients at renal biopsy using interaction studies,
supporting its applicability irrespective of age.
There are several limitations to this study. It is retro-
spective in nature and has a selection bias due to enrolment
of patients with potentially progressive renal course but
excluding rapidly progressive cases. The number of children
is limited; hence the subgroup analysis comparing children
with adults may be underpowered. However, it is noteworthy
that the rates of renal function decline in Table 3 estimated
using combinations of pathological findings are very similar
to adults. Sub-analysis of race and ethnicity is also under-
powered. However, the findings from our unique cohort
with its age spectrum, analyzed by a multivariate analysis
approach with carefully checked clinical data not only at
renal biopsy but also during follow-up, support the value
of the conclusions derived. Validation studies are being
undertaken in North America, Europe, and Asia. A single
clinicopathological classification for all subjects with IgAN,
independent of age, will facilitate the design of clinical trials
and the generalization of their results.
MATERIALS AND METHODS
Pathology definitions
Six pathological variables were selected on the basis of reproducibility
among pathologists, least susceptibility to sampling error, and ease of
scoring in routine practice while avoiding strong colinearity.16 The
selected variables included in the analysis were mesangial hypercellu-
larity, segmental glomerulosclerosis or adhesion, endocapillary
hypercellularity, cellular or fibrocellular crescents, tubular atrophy/
interstitial fibrosis, and arterial intimal thickening. Continuous
variables were also studied as categorical to facilitate the classification.
Receiver operating characteristics curves were plotted for each variable
to determine the optimal cut-offs predicting a worse outcome (the
most clinically relevant outcome was the rate of decline in renal
function, dichotomized to perform this analysis). The cut-off for
mesangial hypercellularity score was 0.5 (equivalent to 50% of
glomeruli showing mild mesangial hypercellularity); segmental
glomerulosclerosis, endocapillary hypercellularity, and extracapillary
proliferation were best categorized as present or absent; tubular
atrophy/interstitial fibrosis and arterial lesions were categorized as
absent/mild (0–25%), moderate (26–50%), or severe (450%). There-
fore, it was concluded that these features should be summarized and
scored as follows:
Mesangial score p0.5 (M0) or above (M1)
Endocapillary hypercellularity absent (E0) or present (E1)
Table 3 | Applicability of the Oxford classification to children and adults
Children (n=59) Adults (n=206)
No. of patients Slope (ml/min/1.73m2/year) s.d. No. of patients Slope (ml/min/1.73m2/year) s.d.
M0, S0, E0 3 1.5 4.1 10 0.5 2.0
M0, S1, E0 4 3.4 5.3 18 1.1 1.8
M1, S0, E0 4 2.0 5.7 27 2.3 4.2
M1, S1, E0 10 5.7 10.1 78 4.5 7.3
M0/1, S0, E1 16 1.4 13.5 5 0.4 3.9
M0/1, S1, E1 22 5.0 10.0 68 4.9 10.0
M0=Mesangial hypercellularity score p0.5.
M1=Mesangial hypercellularity score 40.5.
S0=Segmental glomerulosclerosis: Absent.
S1=Segmental glomerulosclerosis: Present.
E0=Endocapillary hypercellularity: Absent.
E1=Endocapillary hypercellularity: Present.
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Segmental glomerulosclerosis absent (S0) or present (S1)
Tubular atrophy/interstitial fibrosis p25% (T0), 26–50% (T1),
or 450% (T2)
Selection of patients
Patients with biopsy-proven IgAN (defined by standard criteria,
including predominant, or codominant mesangial deposition of
IgA) were included regardless of treatment given. Cases with
advanced renal insufficiency (initial eGFRo30 ml/min per 1.73 m2)
were excluded as well as those with o12 months of follow-up to
minimize error in the estimation of the rate of renal function decline
over a short period of time, recognizing this was likely to exclude the
most acute and rapidly progressive cases. We also excluded subjects
with proteinuria o0.5 g/24 h per 1.73 m2, who are known to be at
low risk of progression, as well as secondary causes of mesangial IgA
deposits such as Henoch–Scho¨nlein purpura and patients with
diabetes mellitus.
Clinical data set
Gender, ethnicity, and age at the time of biopsy were noted.
Children were defined as subjects aged o18 years at biopsy. For
some analyses children p13.0 years at biopsy and adolescents were
considered separately.
Clinical parameters collected within 3 months of the date of
biopsy and during follow-up included systolic and diastolic blood
pressure, weight, height, serum creatinine, and 24-h urine protein or
urine protein-to-creatinine ratio (UP/UCr). Children had a median
number of 8 blood pressure, 7 serum creatinine, and 8 proteinuria
measurements per subject and adults had 7, 6, and 7 measurements,
respectively.
To provide consistency between measurements in adults and
children, and as patients progressed from pediatric age to
adulthood, proteinuria was expressed in g/24 h per 1.73 m2 in
subjects aged less than 18 years. When 24-h urine protein was not
available, UP/UCr (mg/mg) was considered as an estimate of 24-h
protein excretion adjusted for body surface area. UP/UCr was used
almost exclusively in children, representing 42% of all proteinuria
measurements in that group. Proteinuria was considered
in the nephrotic range when was 43 g/24 h per 1.73 m2 or when
UP/UCr43.
Blood pressure was adjusted for gender and age in children.
For each child the standard deviation score for MAP was calculated
for each measurement using gender-specific constants interpolated
for the child’s age;18 MAP was then recalculated from the
standard deviation score using the appropriate constants for an
adult subject.
eGFR was estimated for children using the four-variable MDRD
formula in adults and the Schwartz formula.19,20 To avoid sudden
artificial changes in eGFR and to simplify the estimation of the rate
of renal function decline (see below), we did not switch from the
Schwartz to the MDRD equation for an individual or change
the Schwartz constant from 0.55 to 0.70 for adolescent boys (29
patients); in 6 adolescent boys aged 17 years at the time of biopsy,
only the MDRD equation was used.
Treatment modalities reported were immunosuppressive agents,
fish oil, and several antihypertensive medications, including
renin–angiotensin blockade using an angiotensin-converting enzyme
inhibitor or using angiotensin-receptor blockers. These were
reported as intent to treat regardless of the type or duration of
therapy. Data were verified by communication between two of the
lead authors (S Troyanov and R Coppo) and contributing centers.
Definitions
End-stage renal disease was defined as eGFRo15 ml/min per
1.73 m2. MAP was defined as diastolic pressure plus a third of the
pulse pressure. For each patient, average MAP and proteinuria were
determined for each year of observation. Follow-up MAP and
proteinuria represent the average of these respective values.
Statistical methods
Normally distributed variables were expressed as mean±standard
deviation and compared using Student’s t-test, one-way analysis of
variance, or Pearson test. Non-parametric variables were expressed
as median and range, and compared using Mann–Whitney,
Kruskal–Wallis, or Spearman test. Categorical variables were
expressed in percentages and compared using Pearson w2-test.
Different clinical outcomes were studied to address the predictive
value of the pathological variables. The rate of decline in renal
function for each patient was determined by fitting a straight line
through available data for eGFR using the principle of least squares.
One outlier was censored by visual inspection of line fits in six
subjects. We also studied survival from a combined event (50%
reduction in renal function or end-stage renal disease) using
univariate Cox regression.
The influence of age or ethnicity on the relation between
pathology and the rate of renal function decline was studied using
general linear and survival models with interactions terms. All
P-values were two-tailed and values less than 0.05 were considered
statistically significant. Confidence intervals included 95% of
predicted values. Analyses were peformed using SPSS software
(version 11; SPSS, Chicago, IL, USA).
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